Stephen Albainy-Jenei

Stephen Albainy-Jenei


Recent articles

One Privileged Position

State-owned universities and research institutions are raking in revenue while remaining shielded from lawsuits themselves. Can it last?

Is Off-Label Off-Base?

Off-label prescriptions, for uses lacking scientific support, account for billions in drug revenue.

Merck Gets Punk'd by Thailand

Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug.

The Latest Standpoint on Stents

A panel of experts reaches mixed conclusions on the safety and effectiveness of drug-coated stents.